BiotechTube
Home/Excision BioTherapeutics/Kamel Khalili, Ph.D.
KK

Kamel Khalili, Ph.D.

Co-Founder & Scientific Advisor

Excision BioTherapeutics

Therapeutic Areas

Infectious DiseaseGenetic Disorders

Excision BioTherapeutics Pipeline

DrugIndicationPhase
EBT-101HIV-1 InfectionPhase 1/2
Preclinical ProgramHerpes Simplex Virus (HSV) InfectionPreclinical

Leadership Team at Excision BioTherapeutics

DD
Daniel Dornbusch
Chief Executive Officer
LD
Lisa Danzig, M.D.
Chief Medical Officer
AS
Andrew Schiermeier, Ph.D.
Chief Operating Officer
View full Excision BioTherapeutics profile